(10 years, 11 months ago)
Commons ChamberIn the spirit in which the hon. Gentleman raises this, I think we often do have that debate, and we need to do so. In what were undeniably tough times—we will not debate why they occurred; they occurred for a number of reasons—we were very clear as a coalition Government that those with the broadest shoulders should bear the biggest burden. That is why the top 1% in terms of income pay 30% of the tax going to the Exchequer and why the proportionate increase in tax paid is highest among those who earn the most.
May we have a debate on the procedures that are in place to vet in advance the credentials of organisations that set up Christmas fairs and festivals? My right hon. Friend may have seen reports of the problems with Winter Wonderland in Milton Keynes last weekend. Although trading standards is now looking into it and people have been promised a refund, it left many families bitterly disappointed, and local charities that would have benefited from the fair have lost out.
Yes, my hon. Friend is right; I did indeed see the reports, because my constituency is not far from his. One of the beneficiaries would have been Papworth Trust, which is based in my constituency, so I felt precisely the sense of distress that many families felt about this. It is difficult; hard cases make bad law. The last thing we could contemplate is having some kind of regulatory process before people are able to set up such an event. However, trading standards can certainly look at the consequences and the lessons to be learned from something of the kind he describes.
(12 years, 2 months ago)
Commons ChamberMay we have an urgent debate on community health services? In Milton Keynes the strategic health authority has advised the primary care trust to progress with an NHS-only competitive procurement for our community health service. This goes against a strong local wish for a managed transfer and potentially undermines the innovation and benefit our integrated service is delivering.
My hon. Friend and his neighbour, my hon. Friend the Member for Milton Keynes North (Mark Lancaster), have discussed this and I had intended to meet him. I hope that this might be able to be pursued with my successor as Health Secretary. We are always clear where such changes take place that, while it is important to make progress, to do so quickly and to have a system that is viable, it is vital that it carries the confidence of the local decision makers—the council, the public and the clinical commissioners—in how we go forward.
(12 years, 5 months ago)
Commons ChamberMay I emphasise to my right hon. Friend the strength of local feeling in Milton Keynes that we should retain our integrated community health service, which has worked incredibly well and provides a good role model for elsewhere in the country?
I am grateful to my hon. Friend. The four tests for service change that we have set out—I think rightly—are not just about the tests that must be met before changes can be introduced; they also involve the same considerations that should drive the design of services. If local commissioners, the local authority and local people are supportive of a particular form of organisation, including community services, I would hope that that would provide the basis on which the design of services would proceed.
(12 years, 9 months ago)
Commons Chamber8. What progress he has made in improving outcomes for NHS patients.
Last December, we published data against 30 indicators in the new NHS outcomes framework, which has been supported enthusiastically by patients, by professionals and internationally. The data show that for 25 of the new measures, the NHS improved or maintained performance, including MRSA infections being down by half and C. difficile infections being down by 40% since 2008-09. I expect continuing improvement over the coming years, as the focus on outcomes drives change and improvement.
Campaigns such as “Be Clear on Cancer” are invaluable in ensuring the early detection and treatment of serious conditions. Will the Secretary of State do what he can to ensure that there is proper co-operation between charities and local hospitals about the timing of such campaigns, to ensure that the spike in referrals that follows is dealt with as efficiently as possible?
I will indeed ensure that that happens. We work closely with the cancer charities. We are working with them as we roll out the campaign that was piloted in the east of England to encourage the awareness of symptoms and the earlier diagnosis of bowel cancer. I hope that we will ensure that the services, such as endoscopy services, are available to support that.
(12 years, 11 months ago)
Commons ChamberIn the first instance, the £180 million to which I referred consists of £90 million from the Medical Research Council, which is new money within its existing budget but not at the expense of any other programmes. The other £90 million is provided by the Treasury to the TSB and is new money. None of this comes out of any NHS resources. The implementation will be led by the Medical Research Council, so to that extent it will not be driven by Government.
Does my right hon. Friend believe that there is a threat that parts of the UK pharmaceutical industry might relocate overseas if this package of reforms does not proceed?
There is always that risk because, as my hon. Friend entirely knows, international competition is intense, particularly in the pharmaceutical sector. Following the measures that were announced alongside the Budget in the plan for growth, not least the availability of the patent box from April 2013, it is clear from discussions that my right hon. Friends and I have had with many of the boards of leading international pharmaceutical companies that the United Kingdom is now becoming a better location for investment in pharmaceutical activity than used to be the case. Those companies look very positively at the steps we have taken on regulatory activity and clinical trials, at the steps we are taking on promoting innovation through the value-based pricing system, and in particular, understandably, at the tax measures that my right hon. Friend the Chancellor announced, especially on the patent box.
(13 years ago)
Commons ChamberI will of course answer the question. The answer is that this is entirely driven by clinical issues in a local context. I can tell the hon. Lady that it is very much about trying to improve vascular services, and the judgments being made are local and clinical.
T2. What leadership role do the Government expect the new health and wellbeing boards to play in determining significant NHS service changes in each local area?
The health and wellbeing boards will have a role not only in leading improvements in public health and social care but, through the joint strategic needs assessment and the strategy derived from that, in establishing how services should respond to the needs of the local population. The clinical commissioning group should respond directly to that, and any specific service configuration changes should form part of the commissioning plan. In addition, the local authority, through its scrutiny role, will have a continuing ability to refer those plans for review.